Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SET Technology is developing a DNA/RNA-based vaccine for the prevention of Foot-and-Mouth Disease (FMD) in livestock. FMD is a highly contagious and economically devastating viral disease caused by the Foot-and-mouth disease virus (FMDV), affecting cloven-hoofed animals such as cattle, pigs, and sheep. The vaccine program is currently in the preclinical optimization stage, utilizing SET Technology's nucleic acid delivery platform to elicit protective immune responses against the virus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on foot-and-mouth disease vaccine.